Back
Gritstone Bio Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
30
GRTS
Gritstone Bio
Last Price:
0.95
Seasonality Move:
-20.57%
Buy
77
SYRS
Syros Pharmaceuticals
Last Price:
5.08
Seasonality Move:
6.39%
Sell
30
Gritstone Bio (GRTS)
is a Sell
Is Gritstone Bio a Buy, Sell or Hold?
- The current Gritstone Bio [GRTS] share price is $0.96. The Score for GRTS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- GRTS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Syros Pharmaceuticals (SYRS)
is a Buy
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $5.13. The Score for SYRS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- SYRS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GRTS Stock Price Chart
What is Gritstone Bio's stock price today?
-
The Gritstone Bio share price today is $0.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRTS is experiencing slight buying pressure.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $5.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing slight selling pressure.
GRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | 1879771 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 1.25) | Buy |
| Bollinger Bands (100): | (1.28 - 2.68) | Sell |
SYRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 45.46 | Sell |
| Chaikin Money Flow: | -42729 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.77 - 5.47) | Buy |
| Bollinger Bands (100): | (5.28 - 7.32) | Sell |
GRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.84 | Buy |
| 20-day SMA: | 0.83 | Buy |
| 50-day SMA: | 1.72 | Sell |
| 200-day SMA: | 1.87 | Sell |
| 8-day EMA: | 0.86 | Buy |
| 20-day EMA: | 0.99 | Sell |
| 50-day EMA: | 1.45 | Sell |
| 200-day EMA: | 1.95 | Sell |
SYRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.22 | Sell |
| 20-day SMA: | 5.2 | Sell |
| 50-day SMA: | 5.89 | Sell |
| 200-day SMA: | 4.81 | Buy |
| 8-day EMA: | 5.21 | Sell |
| 20-day EMA: | 5.27 | Sell |
| 50-day EMA: | 5.64 | Sell |
| 200-day EMA: | 5.36 | Sell |
Gritstone Bio Earnings Growth & GRTS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.29 per share, and an increase next year of $0.05 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and a decrease next year of $0.49 per share.
Gritstone Bio Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syros Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||